<!--
source: gpt-40
tags: tests proteins neuroendocrine
-->

# Chromogranin A (CgA) test

The Chromogranin A (CgA) test measures the level of chromogranin A, a protein secreted by neuroendocrine cells. These cells are found throughout the body, particularly in the endocrine and nervous systems, and they release hormones into the bloodstream in response to various signals. Elevated levels of CgA in the blood can indicate the presence of neuroendocrine tumors (NETs), which are abnormal growths that arise from neuroendocrine cells.

CgA testing is particularly useful in diagnosing and monitoring NETs, including carcinoid tumors, pheochromocytomas, and neuroblastomas. These tumors can occur in various organs, such as the pancreas, gastrointestinal tract, and lungs. Besides being a diagnostic tool, the CgA test helps in assessing the effectiveness of treatment and detecting potential recurrences of neuroendocrine tumors.

Several factors can influence CgA levels, including medications like proton pump inhibitors (PPIs), which are commonly used to treat acid reflux and ulcers. Therefore, it is crucial to inform the healthcare provider about all medications being taken before undergoing the test. Elevated CgA levels can also result from other conditions such as chronic atrophic gastritis, renal insufficiency, and inflammatory diseases, necessitating a comprehensive clinical evaluation to interpret the results accurately.
